Potentially Avoidable Hospitalisation in France

Heart Failure Clinical Trial

— HPE-LR  

Official title:

Are Potentially Avoidable Hospitalizations a Good Measure of Access To Primary Care in France?

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02898155
• Other study ID #: 9670
• Status: Completed
• Start date: June 2016
• Est. completion date: March 2017

Study information

• Verified date: February 2019
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Potentially Avoidable Hospitalizations (Pah) Are Studied As An Indirect Measure Of Access To Primary Care And Of The Interface Between Primary And Secondary Care. A Previous Work Unveils Considerable Geographic Variation In The Rate Of Pah In France And Suggest That Primary Care Organization Might Play A Role In This Variation. However, A Limitation Of This Work Lies In The Lack Of Data On Actual Primary Care Utilization.

The Aim Of This Study Is To Analyze The Role Of Primary Care In The Variation Of Potentially Avoidable Hospitalizations At the Zip Code Level, In The French Region Languedoc-Roussillon-Midi-Pyrénées.

The investigator will implement An Ecological Approach In Which The Geographic Variation In The Rate Of Pah Is Analyzed In The French Region Lrmp, Year 2014. Age- And Sex-Adjusted Rate Of Pah By Zip Codes (N=612) Is Modeled Using A Spatial Regression Model.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 12000
• Est. completion date: March 2017
• Est. primary completion date: December 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion criteria:

• year 2014

• LRMP region

• Hospital admission in any public or private hospital

Exclusion criteria:

Related Conditions & MeSH terms

• COPD
• Diabetes
• Heart Failure

Intervention

Other:
• measure of access to primary care and of the Interface Between Primary ans Secondary Care

Locations

Country	Name	City	State
France	UHMontpellier	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of potentially avoidable admissions		24 months
Secondary	Standardized Rate of potentially avoidable admissions		24 months